2026Q1
| Insider | Role (last 12 mo) | Shares held | Filed at |
|---|---|---|---|
| HighCape Capital, L.P. | Director | 9,520,232 | Mar 13, 2025 |
| HighCape Co-Investment Vehicle II, LLC | 10% Owner | 9,520,232 | Mar 13, 2025 |
| Rakin Kevin | Director | 9,520,232 | Mar 13, 2025 |
| Zuga Matt | Director | 9,520,232 | Mar 13, 2025 |
| HighCape Partners GP, LLC | 10% Owner | 9,520,232 | Mar 13, 2025 |
| Exec date | Filing date | Insider | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jan 30, 2026 | Feb 2, 2026 | RAKIN KEVIN | Director | Buy | 82.5 | +70,000 | 1.36% | ✗ | $74.2K |
| Jan 30, 2026 | Feb 2, 2026 | NEELS GUIDO J | Director | Buy | 91.3 | +20,000 | 20.25% | ✗ | $20.8K |
| Jan 28, 2026 | Jan 29, 2026 | NEELS GUIDO J | Director | Buy | 91.3 | +30,000 | 43.64% | ✗ | $31.8K |
| Jan 1, 2026 | Jan 5, 2026 | Williams Michelle LeRoux | CHIEF SCIENTIFIC OFFICER | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 1, 2026 | Jan 5, 2026 | Ferguson Matthew | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 1, 2026 | Jan 5, 2026 | Mills C Randal | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 17, 2025 | Dec 19, 2025 | RAKIN KEVIN | Director | Buy | 68.8 | +50,000 | 0.98% | ✗ | $26K |
| Dec 11, 2025 | Dec 19, 2025 | RAKIN KEVIN | Director | Neutral | 27.5 | -4,505,941 | -46.88% | ✗ | - |
| Dec 17, 2025 | Dec 18, 2025 | Colpman David | Director | Buy | 90.0 | +12,500 | 67.21% | ✗ | $6.4K |
| Dec 17, 2025 | Dec 18, 2025 | Makes Brigid | Director | Buy | 91.3 | +25,000 | 1250.00% | ✗ | $13K |
| Dec 17, 2025 | Dec 18, 2025 | Mills C Randal | CEO | Buy | 67.5 | +3,000 | 0.80% | ✗ | $1.5K |
| Dec 17, 2025 | Dec 18, 2025 | Ferguson Matthew | CFO | Buy | 91.3 | +60,000 | 15.50% | ✗ | $31.8K |
| Dec 11, 2025 | Dec 17, 2025 | RAKIN KEVIN | Director | Neutral | 27.5 | -4,505,941 | -46.88% | ✗ | - |
| Dec 11, 2025 | Dec 15, 2025 | RAKIN KEVIN | Director | Neutral | 27.5 | -4,372,497 | -46.14% | ✗ | - |
| Dec 10, 2025 | Dec 12, 2025 | Williams Michelle LeRoux | CHIEF SCIENTIFIC OFFICER | Sell | 47.5 | -3,951 | -3.73% | ✗ | $2.8K |
| Dec 10, 2025 | Dec 12, 2025 | Ferguson Matthew | CFO | Sell | 47.5 | -4,461 | -1.14% | ✗ | $3.1K |
| Dec 10, 2025 | Dec 12, 2025 | Mills C Randal | CEO | Sell | 47.5 | -9,664 | -2.50% | ✗ | $6.8K |
| Dec 1, 2025 | Dec 3, 2025 | Ferguson Matthew | CFO | Buy | 82.5 | +10,000 | 2.71% | ✗ | $6.6K |
| Dec 1, 2025 | Dec 2, 2025 | NEELS GUIDO J | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 24, 2025 | Nov 26, 2025 | Mills C Randal | CEO | Buy | 77.5 | +5,000 | 1.41% | ✗ | $3K |
| Nov 17, 2025 | Nov 19, 2025 | Colpman David | Director | Buy | 91.3 | +15,500 | 500.32% | ✗ | $11.5K |
| Nov 13, 2025 | Nov 14, 2025 | Mills C Randal | CEO | Buy | 83.8 | +13,500 | 3.97% | ✗ | $10.1K |
| Oct 9, 2025 | Oct 14, 2025 | NEELS GUIDO J | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 14, 2025 | NEELS GUIDO J | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Sep 10, 2025 | Sep 11, 2025 | Williams Michelle LeRoux | CHIEF SCIENTIFIC OFFICER | Sell | 47.5 | -3,950 | -4.06% | ✗ | $5.4K |
| Sep 10, 2025 | Sep 11, 2025 | Ferguson Matthew | CFO | Sell | 46.3 | -10,348 | -2.73% | ✗ | $14.1K |
| Sep 10, 2025 | Sep 11, 2025 | Mills C Randal | CEO | Sell | 46.3 | -9,664 | -2.78% | ✗ | $13.1K |
| Jun 21, 2025 | Jun 24, 2025 | Mills C Randal | CEO | Sell | 46.3 | -8,019 | -2.44% | ✗ | $14.5K |
| Jun 10, 2025 | Jun 12, 2025 | Ferguson Matthew | CFO | Sell | 47.5 | -4,461 | -1.26% | ✗ | $8.9K |
| Jun 10, 2025 | Jun 12, 2025 | Mills C Randal | CEO | Sell | 46.3 | -9,664 | -3.05% | ✗ | $19.2K |
| Jun 10, 2025 | Jun 12, 2025 | Williams Michelle LeRoux | CHIEF SCIENTIFIC OFFICER | Sell | 47.5 | -3,951 | -4.45% | ✗ | $7.9K |
| May 29, 2025 | Jun 2, 2025 | Jordan Maybelle | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 29, 2025 | Jun 2, 2025 | RAKIN KEVIN | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 29, 2025 | Jun 2, 2025 | Zuga Matt | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 29, 2025 | Jun 2, 2025 | Colpman David | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 29, 2025 | Jun 2, 2025 | Makes Brigid | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 3, 2025 | Mar 13, 2025 | HighCape Capital, L.P. | Director | Buy | 92.5 | +420,000 | 4.62% | ✗ | $1.1M |
| Feb 3, 2025 | Mar 13, 2025 | HighCape Capital, L.P. | Director | Buy | 92.5 | +420,000 | 4.62% | ✗ | $1.1M |
| Mar 8, 2025 | Mar 11, 2025 | Ferguson Matthew | CFO | Sell | 46.3 | -12,413 | -1.83% | ✗ | $37.1K |
| Mar 10, 2025 | Mar 11, 2025 | Mills C Randal | CEO | Sell | 46.3 | -10,706 | -3.57% | ✗ | $32.1K |
| Mar 10, 2025 | Mar 11, 2025 | Williams Michelle LeRoux | CHIEF SCIENTIFIC OFFICER | Sell | 46.3 | -4,613 | -5.70% | ✗ | $13.8K |
| Dec 10, 2024 | Dec 11, 2024 | Ferguson Matthew | CFO | Sell | 46.3 | -4,461 | -1.38% | ✗ | $19.1K |
| Dec 10, 2024 | Dec 11, 2024 | Mills C Randal | CEO | Sell | 42.5 | -13,726 | -4.88% | ✗ | $58.9K |
| Dec 10, 2024 | Dec 11, 2024 | Williams Michelle LeRoux | CHIEF SCIENTIFIC OFFICER | Sell | 46.3 | -3,950 | -5.46% | ✗ | $16.9K |
| Sep 10, 2024 | Sep 12, 2024 | Williams Michelle LeRoux | CHIEF SCIENTIFIC OFFICER | Sell | 46.3 | -3,951 | -6.19% | ✗ | $16.4K |
| Sep 10, 2024 | Sep 12, 2024 | Mills C Randal | CEO | Sell | 46.3 | -9,664 | -3.67% | ✗ | $40K |
| Sep 10, 2024 | Sep 12, 2024 | Ferguson Matthew | CFO | Sell | 46.3 | -10,527 | -3.28% | ✗ | $43.6K |
| Aug 12, 2024 | Aug 13, 2024 | Mills C Randal | CEO | Sell | 42.5 | -58,659 | -20.06% | ✗ | $166.6K |
| Aug 12, 2024 | Aug 13, 2024 | Williams Michelle LeRoux | CHIEF SCIENTIFIC OFFICER | Sell | 46.3 | -15,800 | -23.55% | ✗ | $44.9K |
| Aug 12, 2024 | Aug 13, 2024 | Ferguson Matthew | CFO | Sell | 42.5 | -17,840 | -5.80% | ✗ | $50.7K |
| Jul 30, 2024 | Aug 1, 2024 | HighCape Capital, L.P. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 30, 2024 | Aug 1, 2024 | HighCape Capital, LLC | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 31, 2024 | Jul 31, 2024 | Ferguson Matthew | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 21, 2024 | Jun 25, 2024 | Mills C Randal | CEO | Sell | 46.3 | -8,019 | -5.81% | ✗ | $28.1K |
| Jun 10, 2024 | Jun 12, 2024 | Williams Michelle LeRoux | CHIEF SCIENTIFIC OFFICER | Sell | 46.3 | -7,900 | -31.60% | ✗ | $27.4K |
| Jun 10, 2024 | Jun 12, 2024 | Ferguson Matthew | CFO | Sell | 46.3 | -8,920 | -5.52% | ✗ | $31K |
| Jun 10, 2024 | Jun 12, 2024 | Mills C Randal | CEO | Sell | 42.5 | -19,327 | -14.33% | ✗ | $67.1K |
| Jun 6, 2024 | Jun 10, 2024 | Jordan Maybelle | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 6, 2024 | Jun 10, 2024 | RAKIN KEVIN | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 6, 2024 | Jun 10, 2024 | Makes Brigid | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 6, 2024 | Jun 10, 2024 | Zuga Matt | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 6, 2024 | Jun 10, 2024 | Colpman David | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 8, 2024 | Mar 14, 2024 | Ferguson Matthew | CFO | Sell | 52.5 | -528 | -0.43% | ✗ | $1.7K |
| Mar 23, 2023 | Feb 20, 2024 | Birchview Capital, LP | Other | Buy | 90.0 | +140,000 | 9.24% | ✗ | $207K |
| Feb 20, 2024 | Birchview Capital, LP | Other | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 31, 2024 | Feb 2, 2024 | Mills C Randal | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 31, 2024 | Feb 2, 2024 | Ferguson Matthew | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 31, 2024 | Feb 2, 2024 | Williams Michelle LeRoux | CHIEF SCIENTIFIC OFFICER | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 28, 2023 | Jan 8, 2024 | HighCape Capital, LLC | 10% Owner | Neutral | 27.5 | -1,436,077 | -17.03% | ✗ | - |
| Dec 28, 2023 | Jan 8, 2024 | HighCape Capital, L.P. | Director | Neutral | 27.5 | -1,436,077 | -17.03% | ✗ | - |
| Sep 21, 2021 | Oct 5, 2023 | HighCape Capital, LLC | 10% Owner | Neutral | 90.0 | +2,837,128 | 50.68% | ✗ | - |
| Sep 21, 2021 | Oct 5, 2023 | HighCape Capital, L.P. | Director | Neutral | 90.0 | +2,837,128 | 50.68% | ✗ | - |
| Oct 5, 2023 | Elutia PIPE Investment, LP | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Sep 21, 2023 | Sep 21, 2023 | Ferguson Matthew | CFO | Neutral | 90.0 | +70,053 | 138.81% | ✗ | - |
| Jun 21, 2023 | Jun 23, 2023 | Mills C Randal | CEO | Sell | 46.3 | -7,772 | -11.03% | ✗ | $18.7K |
| Jun 8, 2023 | Jun 12, 2023 | HighCape Capital, L.P. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 8, 2023 | Jun 12, 2023 | Makes Brigid | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 8, 2023 | Jun 12, 2023 | Colpman David | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 8, 2023 | Jun 12, 2023 | Jordan Maybelle | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 27, 2023 | Apr 28, 2023 | Mills C Randal | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 23, 2023 | Mar 27, 2023 | Birchview Capital, LP | 10% Owner | Buy | 90.0 | +140,000 | 9.24% | ✗ | $207K |
| Mar 8, 2023 | Mar 9, 2023 | Englese Thomas | CHIEF COMMERCIAL OFFICER | Sell | 47.5 | -289 | -1.59% | ✗ | $1.2K |
| Mar 8, 2023 | Mar 9, 2023 | Ferguson Matthew | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 11, 2022 | Feb 13, 2023 | Birchview Capital, LP | 10% Owner | Buy | 92.5 | +97,261 | 6.86% | ✗ | $398.2K |
| Feb 13, 2023 | Birchview Capital, LP | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Dec 22, 2022 | Dec 28, 2022 | HighCape Partners GP II, LLC | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 22, 2022 | Dec 27, 2022 | HighCape Capital, L.P. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 15, 2022 | Dec 16, 2022 | Colpman David | Director | Buy | 91.3 | +3,098 | 100.00% | ✗ | $12.1K |
| Dec 15, 2022 | HighCape Partners GP II, LLC | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Dec 9, 2022 | Dec 12, 2022 | Makes Brigid | Director | Buy | 90.0 | +2,000 | 100.00% | ✗ | $7.3K |
| Dec 5, 2022 | Dec 7, 2022 | HighCape Capital, L.P. | Director | Buy | 100.0 | +735,000 | 14.84% | ✗ | $3.5M |
| Dec 2, 2022 | Dec 5, 2022 | Ferguson Matthew | CFO | Buy | 95.0 | +28,000 | 162.63% | ✗ | $126.4K |
| Oct 20, 2022 | Oct 24, 2022 | Williams Michelle LeRoux | CHIEF SCIENTIFIC OFFICER | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 20, 2022 | Oct 24, 2022 | Colpman David | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 21, 2022 | Colpman David | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Sep 8, 2022 | Sep 12, 2022 | Ferguson Matthew | CFO | Sell | 46.3 | -4,798 | -21.79% | ✗ | $35K |
| Sep 8, 2022 | Sep 12, 2022 | Edwards Peter G | GENERAL COUNSEL | Sell | 47.5 | -1,127 | -24.37% | ✗ | $8.2K |
| Sep 8, 2022 | Sep 12, 2022 | Englese Thomas | CHIEF COMMERCIAL OFFICER | Sell | 46.3 | -4,728 | -21.49% | ✗ | $34.5K |
| Sep 8, 2022 | Sep 12, 2022 | Riebman Jerome | CHIEF MEDICAL OFFICER | Sell | 46.3 | -5,104 | -25.40% | ✗ | $37.3K |
| Aug 29, 2022 | Williams Michelle LeRoux | Chief Scientific Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |